OTTAWA, ONTARIO–(Marketwired – Dec. 13, 2017) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid -based drug development and discovery, is pleased to announce that the company has signed an exclusive research and … Read More
The post Tetra Bio-Pharma Reinforces its Development Program by Signing Research & Development … appeared first on Dagga Magazine.